Evidence map›Paper›PMID 30353469›Full record

ArticleJournal of microbiology (Seoul, Korea)2018

Photodynamic antimicrobial activity of new porphyrin derivatives against methicillin resistant Staphylococcus aureus.

Hüseyin Taslı, Ayse Akbıyık, Nermin Topaloğlu, Vildan Alptüzün, Sülünay Parlar

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of microbiology (Seoul, Korea), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Antimicrobial photodynamic therapy using tetra-cationic porphyrins with peripheral platinum(II) and palladium(II) complexes against multidrug-resistant bacteria isolated from canine otitis.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026
    Article
  2. Article
  3. Photo-Inactivation ofAntibiotics (Basel, Switzerland) · 2023
    Article
  4. Review
  5. Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2020
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hüseyin TaslıDepartment of Pharmaceutical Microbiology, Faculty of Pharmacy, Ege University, 35100, Izmir, Turkey. huseyin.tasli@ege.edu.tr.
Ayse AkbıyıkDepartment of Nursing, Faculty of Health Sciences, Izmir Katip Celebi University, 35620, Izmir, Turkey.
Nermin TopaloğluDepartment of Biomedical Engineering, Faculty of Engineering and Architecture Izmir Katip Celebi University, 35620, Izmir, Turkey.
Vildan AlptüzünDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Ege University, 35100, Izmir, Turkey.
Sülünay ParlarDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Ege University, 35100, Izmir, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methicillin resistant Staphylococcus aureus (MRSA) with multiple drug resistance patterns is frequently isolated from skin and soft tissue infections that are involved in chronic wounds. Today, difficulties in the treatment of MRSA associated infections have led to the development of alternative approaches such as antimicrobial photodynamic therapy. This study aimed to investigate photoinactivation with cationic porphyrin derivative compounds against MRSA in in-vitro conditions. In the study, MRSA clinical isolates with different antibiotic resistance profiles were used. The newly synthesized cationic porphyrin derivatives (P

Indexed as

Anti-Bacterial AgentsAnti-Infective AgentsHumansLasers, SemiconductorMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsMicrobial ViabilityPhotochemotherapyPhotosensitizing AgentsPorphyrinsStaphylococcus aureusAnti-Bacterial AgentsAnti-Infective AgentsPhotosensitizing AgentsPorphyrinsantimicrobial photodynamic therapycationic porphyrinsMRSAmultidrug resistantStaphylococcus aureuswound infections

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.